
NovaBay Pharmaceuticals, Inc.
USD1.47
-0.48 (-24.62%)
CEO
Michael Kazley
IPO Date
2007-10-26
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Open
$1.47
Prev. Close
$1.95
Day Low
$1.47
Day High
$1.47
52W Low
$1.11
52W High
$99.75
Market Cap
$0.04B
Volume
0.09M
| 18 Sept 2019 |
| Ladenburg Thalmann |
| Buy |
| Buy |
| maintain |
| 13 Mar 2019 | H.C. Wainwright | Buy | Neutral | downgrade |
| 26 Mar 2018 | Roth Capital | Buy | Neutral | downgrade |
| 5 Jun 2017 | Roth Capital | Buy | Buy | maintain |
| 7 Mar 2016 | Maxim Group | Buy | Hold | downgrade |
| 30 Apr 2015 | Maxim Group | Buy | Buy | maintain |
| 6 Mar 2013 | Ascendiant Capital | Strong Buy | Buy | downgrade |